Increased platelet aggregation and activation in peripheral arterial disease

Area of Science:

• Cardiovascular Medicine
• Hematology
• Vascular Surgery

Background:

• Peripheral arterial disease (PAD) significantly increases cardiovascular mortality.
• Standard antiplatelet therapies may not provide consistent benefits across all patient subgroups.
• Understanding platelet function variations is crucial for optimizing treatment.

Purpose of the Study:

• To compare platelet function in patients with lower limb PAD, carotid disease, and abdominal aortic aneurysm (AAA).
• To assess platelet activation and aggregation markers in these patient groups against healthy controls.
• To investigate the impact of different vascular conditions on platelet behavior.

Main Methods:

• Studied patients with lower limb PAD (n=20), carotid disease (n=40), AAA (n=13), and healthy controls (n=20).
• Utilized whole blood methods to measure spontaneous platelet aggregation (SPA) and adenosine diphosphate (ADP)/collagen-induced aggregation.
• Employed flow cytometry to detect platelet P-selectin and PAC-1 antigen as markers of activation and aggregation.

Main Results:

• Patients with lower limb PAD or AAA showed higher baseline SPA than controls (p < 0.01).
• Carotid artery disease patients exhibited significantly higher collagen-induced aggregation (p < 0.01) and P-selectin expression (p < 0.05) versus controls.
• No significant differences in ADP-induced aggregation or PAC-1 binding were observed between PAD patients and controls.

Conclusions:

• Platelet hyperactivity persists in PAD patients despite antiplatelet therapy, indicating a need for enhanced treatment strategies.
• Findings suggest that specific vascular conditions like PAD, carotid disease, and AAA are associated with distinct patterns of platelet activation.
• Further research into novel antiplatelet strategies is warranted to improve outcomes for these high-risk cardiovascular patients.